(Q51019130)

27 March 2018

title

Heparanase promotes lymphangiogenesis and tumor invasion in pancreatic neuroendocrine tumors. (English)

1 reference

27 March 2018

1 reference

1 reference

K E Hunter

1

1 reference

27 March 2018

C Palermo

2

1 reference

27 March 2018

J C Kester

3

1 reference

27 March 2018

K Simpson

4

1 reference

27 March 2018

J-P Li

5

1 reference

27 March 2018

L H Tang

6

1 reference

27 March 2018

D S Klimstra

7

1 reference

27 March 2018

I Vlodavsky

8

1 reference

27 March 2018

J A Joyce

9

1 reference

27 March 2018

language of work or name

English

0 references

publication date

6 May 2013

1 reference

27 March 2018

published in

Oncogene

1 reference

27 March 2018

volume

33

1 reference

27 March 2018

issue

14

1 reference

27 March 2018

page(s)

1799-1808

1 reference

27 March 2018

https://scigraph.springernature.com/pub.10.1038/onc.2013.142

exact match

0 references

cites work

Microenvironmental regulation of metastasis

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.142

Significance of heparanase in cancer and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.142

A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.142

Population-based study of islet cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.142

One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.142

DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.142

The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.142

Differential contribution to neuroendocrine tumorigenesis of parallel egfr signaling in cancer cells and pericytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.142

Newly generated heparanase knock-out mice unravel co-regulation of heparanase and matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.142

Transgenic expression of mammalian heparanase uncovers physiological functions of heparan sulfate in tissue morphogenesis, vascularization, and feeding behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.142

Elevated levels of IGF-1 receptor convey invasive and metastatic capability in a mouse model of pancreatic islet tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.142

IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.142

Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.142

Myeloid cells and lymphangiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.142

Myeloid cells contribute to tumor lymphangiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.142

Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.142

Lymphangiogenesis: Molecular mechanisms and future promise

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.142

A systems biology approach for the investigation of the heparin/heparan sulfate interactome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.142

Interactions between heparan sulfate and proteins-design and functional implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.142

The heparanase system and tumor metastasis: is heparanase the seed and soil?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.142

Peripheral mural cell recruitment requires cell-autonomous heparan sulfate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.142

Heparanase induces VEGF C and facilitates tumor lymphangiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.142

Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.142

'Green mice' as a source of ubiquitous green cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.142

Gene Amplifications in Well-Differentiated Pancreatic Neuroendocrine Tumors Inactivate the p53 Pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.142

Determining Prognosis in Patients With Pancreatic Endocrine Neoplasms: Can the WHO Classification System Be Simplified?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.142

Translational medicine: Cancer lessons from mice to humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.142

Deficiency of the macrophage growth factor CSF-1 disrupts pancreatic neuroendocrine tumor development

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2013.142

31 March 2020

Identifiers

DOI

10.1038/ONC.2013.142

1 reference

27 March 2018

Dimensions Publication ID

1037239146

0 references

1 reference

27 March 2018